By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Edge Therapeutics 

NJIT-EDC Biotechnology Incubator
139 South Street, Suite 102
New Providence  New Jersey  07974  U.S.A.
Phone: 800-208-EDGE Fax: 800-208-3433


SEARCH JOBS


Industry
Biotechnology






Company News
Edge Therapeutics Reports First Quarter 2017 Financial Results And Continued Operational Progress 5/3/2017 10:55:13 AM
Edge Therapeutics Announces Conference Call On May 3, 2017 To Discuss First Quarter 2017 Financial Results 4/21/2017 8:19:44 AM
Edge Therapeutics Announces $18 Million Registered Direct Offering Of Common Stock 4/19/2017 8:39:26 AM
Edge Therapeutics Announces First Patient Randomized In Study Of Intracisternal Administration Of EG-1962 In Adults With Aneurysmal Subarachnoid Hemorrhage 3/13/2017 8:26:48 AM
Edge Therapeutics Reports Fourth Quarter And Full Year 2016 Financial Results 3/2/2017 9:03:45 AM
Edge Therapeutics Announces Conference Call On March 2, 2017 To Discuss Fourth Quarter And Full Year 2016 Financial Results 2/23/2017 11:17:27 AM
Edge Therapeutics Appoints Alyssa Wyant As Senior Vice President, Regulatory Affairs And Makes Inducement Grant Under NASDAQ Rule 5635(C)(4) 2/21/2017 10:55:22 AM
Edge Therapeutics Announces Publication Of Phase I/II Data On EG-1962 For The Treatment Of Aneurysmal Subarachnoid Hemorrhage In Peer-Reviewed Medical Journal, Stroke 12/12/2016 8:05:35 AM
Edge Therapeutics Reports Third Quarter Financial Results 11/1/2016 11:02:59 AM
Edge Therapeutics To Host Conference Call On November 1, 2016 To Discuss Third Quarter Financial Results 10/25/2016 8:18:02 AM
123456
//-->